Float Short %

14.15

Margin Of Safety %

Put/Call OI Ratio

0.42

EPS Next Q Diff

-0.07

EPS Last/This Y

-0.98

EPS This/Next Y

-0.68

Price

21.33

Target Price

57.25

Analyst Recom

1.29

Performance Q

3.29

Relative Volume

0.98

Beta

1.14

Ticker: CLDX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-05-08	CLDX	19.52	0.68	0.67	8172
2025-05-09	CLDX	18.34	0.67	0.31	8231
2025-05-12	CLDX	20.18	0.65	0.28	8512
2025-05-13	CLDX	19.61	0.64	999.99	8601
2025-05-14	CLDX	18.95	0.64	0.00	8606
2025-05-15	CLDX	20.08	0.64	0.00	8567
2025-05-16	CLDX	20.45	0.57	0.00	9138
2025-05-19	CLDX	20.91	0.53	0.00	5970
2025-05-20	CLDX	20.49	0.43	0.04	6949
2025-05-21	CLDX	19.93	0.42	0.00	7002
2025-05-22	CLDX	20.39	0.40	999.99	7301
2025-05-23	CLDX	20.38	0.45	0.00	7580
2025-05-27	CLDX	19.8	0.45	0.20	7581
2025-05-28	CLDX	18.54	0.45	2.00	7591
2025-05-29	CLDX	19.82	0.45	0.74	7596
2025-05-30	CLDX	19.77	0.45	0.06	7629
2025-06-02	CLDX	19.97	0.42	0.75	8080
2025-06-03	CLDX	19.85	0.43	0.00	8125
2025-06-04	CLDX	19.67	0.42	0.00	8147
2025-06-05	CLDX	19.51	0.42	0.17	8156
2025-06-06	CLDX	21.36	0.42	0.11	8176
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-05-08	CLDX	19.51	-32.6	-72.6	-3.26
2025-05-09	CLDX	18.32	-32.6	-19.3	-3.26
2025-05-12	CLDX	20.18	-32.6	-110.4	-3.26
2025-05-13	CLDX	19.62	-53.0	-18.0	-3.43
2025-05-14	CLDX	18.92	-55.8	-13.6	-3.43
2025-05-15	CLDX	20.12	-55.8	-65.1	-3.43
2025-05-16	CLDX	20.45	-55.8	-40.7	-3.43
2025-05-19	CLDX	20.91	-55.8	-42.9	-3.43
2025-05-20	CLDX	20.50	-55.8	-22.5	-3.43
2025-05-21	CLDX	19.96	-55.8	-19.2	-3.43
2025-05-22	CLDX	20.37	-55.8	-42.5	-3.43
2025-05-23	CLDX	20.34	-55.8	-31.3	-3.43
2025-05-27	CLDX	19.78	-55.8	-18.2	-3.43
2025-05-28	CLDX	18.84	-55.8	-8.0	-3.43
2025-05-29	CLDX	19.83	-55.8	-65.7	-3.43
2025-05-30	CLDX	19.78	-55.8	-30.5	-3.43
2025-06-02	CLDX	19.97	-55.8	-37.7	-3.43
2025-06-03	CLDX	19.87	-55.8	-29.2	-3.43
2025-06-04	CLDX	19.67	-55.8	-27.0	-3.43
2025-06-05	CLDX	19.53	-55.8	-28.1	-3.43
2025-06-06	CLDX	21.33	-55.8	-79.9	-3.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-05-08	CLDX	0.69	10.05	13.57
2025-05-09	CLDX	0.69	10.05	13.57
2025-05-12	CLDX	0.69	11.04	13.92
2025-05-13	CLDX	0.00	11.04	13.92
2025-05-14	CLDX	0.00	11.04	13.92
2025-05-15	CLDX	0.00	11.04	13.92
2025-05-16	CLDX	0.00	11.04	13.92
2025-05-19	CLDX	0.00	5.43	13.97
2025-05-20	CLDX	0.00	5.43	13.97
2025-05-21	CLDX	0.00	5.43	13.97
2025-05-22	CLDX	0.00	5.43	13.97
2025-05-23	CLDX	0.00	5.43	13.97
2025-05-27	CLDX	0.00	-5.75	13.97
2025-05-28	CLDX	0.00	-5.75	14.15
2025-05-29	CLDX	0.00	-5.75	14.15
2025-05-30	CLDX	0.00	-5.75	14.15
2025-06-02	CLDX	0.00	-5.07	14.15
2025-06-03	CLDX	0.00	-5.07	14.15
2025-06-04	CLDX	0.00	-5.07	14.15
2025-06-05	CLDX	0.00	-5.07	14.15
2025-06-06	CLDX	0.00	-5.07	14.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.81

Avg. EPS Est. Current Quarter

-0.84

Avg. EPS Est. Next Quarter

-0.88

Insider Transactions

Institutional Transactions

-5.07

Beta

1.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

62.7

Max Drawdown 5-Year %

-73.1

Target Price

57.25

P/E

Forward P/E

PEG

P/S

187.5

P/B

2.02

P/Free Cash Flow

EPS

-2.7

Average EPS Est. Cur. Y

-3.43

EPS Next Y. (Est.)

-4.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2366.07

Relative Volume

0.98

Return on Equity vs Sector %

-49.5

Return on Equity vs Industry %

-31.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.16

EBIT Estimation

-79.9

Celldex Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 186

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.

stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today

news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance

stock history CLDX – Celldex Therapeutics, Inc. invest stock market

stock prices CLDX premarket after hours

ticker CLDX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CLDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y